Abstract:Abstract Introduction Vitiligo is an autoimmune skin disease. Psychological disruption can lead to clinical worsening and impact sleep quality of patients, in a bidirectional manner. Sleep regulates the immune system, and cytokines expression, including interleukin (IL)-6 and IL-17A (pro-inflammatory) and IL-4 and IL-10 (anti-inflammatory), which are linked to circadian rhythm and vitiligo immunopathogenesis. This study aimed to analyse cytokine profiles in a vitiligo sample; and verify any association with subjective sleep. Methods The study comprised 30 patients with vitiligo, and 26 healthy controls, following ethical guidelines. Quality of life and sleep questionnaires were completed: Dermatology Life Quality Index (DLQI), Short-Form Health Survey (SF-36), Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI). Seven serum cytokines were measured through a 7-plex kit: IFN-γ, IL-4, IL-6, IL-10, IL-12 p40, IL-17A and TNF-α. Previous treatment with ultraviolet B phototherapy was registered. Generalized Linear Model test was used for statistical analysis. Results PSQI total score and domain 4 (sleep efficiency) were statistically worse in the vitiligo sample (both p=0.01). The PSQI means were 9.07 (vitiligo) and 6.66 (controls). Final scores of SF-36 and ISI were not statistically different between groups, although numerically worse in vitiligo group. The SF-36 domains “body pain”, “social aspects”, “physical limitation” and “emotional limitation” were statistically worse in vitiligo group. The DLQI mean (vitiligo group) indicated mild to moderate impact on quality of life (5.57). Cytokine levels were not different between groups, nor when analysed with PSQI. Regarding ISI, higher scores were related to increased IL-17A in vitiligo group (p=0.01). Increasing IL-4, IL-6 and IL-10 were associated with previous phototherapy (p=0.03; p=0.03 and p=0.04, respectively). Conclusion The vitiligo group presented worse sleep, as expected. Body pain predominated in vitiligo sample; hyperalgesia can occur in poor sleep, impairing quality of life. Emotional limitation can be enhanced by or aggravate physical limitation and pain. Elevated ISI scores (more severe insomnia) were related to increased IL-17A levels. The IL-4, IL-6 and IL-10, with circadian behaviour, were associated to phototherapy, which has immunomodulatory role. Poor sleep and impaired vitiligo may interact bidirectionally; cytokine regulation should be further investigated in this complex relationship. Support (if any) AFIP, CAPES, CNPq and FAPESP.

Immunohistochemical Expression of CXCL 10 in Vitiligo

DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10

Identification of Upregulating Genes, Transcription Factors, and miRNAs in Vitiligo. In silico Study

CXCL9 As a Key Biomarker of Vitiligo Activity and Prediction of the Success of Cultured Melanocyte Transplantation

Vitiligo: A focus on pathogenesis and its therapeutic implications

The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response

Melanocyte-keratinocyte cross-talk in vitiligo

Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion

Circulating CCL20: A Potential Biomarker for Active Vitiligo Together with the Number of Th1/17 Cells.

Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo

Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes

Serum level of YKL-40, C-reactive protein and ESR in Patients with Vitiligo

Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy

Dysregulated tryptophan metabolism and AhR pathway contributed to CXCL10 upregulation in stable non-segmental vitiligo

Multimodal Analyses of Stable Vitiligo Skin Identify Tissue Interactions That Control Disease Persistence

Increased Expression of Toll-like Receptor 7 and 9 in Vitiligo Melanocytes: a Pilot Study

Identification of the Role of Wnt/-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo

Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications

The enigma and challenges of vitiligo pathophysiology and treatment

Analysis of CD8+ TCRβ Chain repertoire in peripheral blood of vitiligo via high-throughput sequencing.

0918 A Cross-sectional Study on the Cytokine Profiles and Immunological Relationship Between Vitiligo and Sleep Quality